RO-104

N/A

Report date: 2024/05/21 11:13:35

Base Information

Drug NameRO-104
Drug Alias NameRO-104
ClassificationBiologics
Mechanisms of ActionVascular endothelial growth factor C inhibitorsVascular endothelial growth factor A inhibitorsAnti-Angiopoietin-2
TargetsVascular endothelial growth factor AVascular endothelial growth factor CAngiopoietin-2
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRevOpsis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRevOpsis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A